BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Curcio D, Cané A, Fernández FA, Correa J. Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis. Infect Dis Ther 2019;8:87-103. [PMID: 30659481 DOI: 10.1007/s40121-019-0231-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Dirks EE, Luković JA, Peltroche-Llacsahuanga H, Herrmann A, Mellmann A, Arvand M. Molecular Epidemiology, Clinical Course, and Implementation of Specific Hygiene Measures in Hospitalised Patients with Clostridioides difficile Infection in Brandenburg, Germany. Microorganisms 2022;11. [PMID: 36677336 DOI: 10.3390/microorganisms11010044] [Reference Citation Analysis]
2 Legenza L, Coetzee R, Rose WE, Esack T, Crombie K, Mina M, Safdar N, Barnett SG. Application of consolidated framework for implementation research to improve Clostridioides difficile infection management in district hospitals. Res Social Adm Pharm 2022;18:4100-11. [PMID: 35981939 DOI: 10.1016/j.sapharm.2022.07.046] [Reference Citation Analysis]
3 Noori M, Azimirad M, Eslami G, Looha MA, Yadegar A, Ghalavand Z, Zali MR. Surface layer protein A from hypervirulent Clostridioides difficile ribotypes induce significant changes in the gene expression of tight junctions and inflammatory response in human intestinal epithelial cells. BMC Microbiol 2022;22:259. [PMID: 36303110 DOI: 10.1186/s12866-022-02665-0] [Reference Citation Analysis]
4 Zyoud SH. Global research on Clostridium difficile-associated diarrhoea: A visualized study. World J Gastroenterol 2022; 28(28): 3720-3731 [DOI: 10.3748/wjg.v28.i28.3720] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Olmedo M, Kestler M, Valerio M, Padilla B, Rodríguez González C, Chamarro E, Machado M, Álvarez-Uría A, Alcalá L, Muñoz P, Bouza E. Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience. Rev Esp Quimioter 2022;35:279-83. [PMID: 35279984 DOI: 10.37201/req/120.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Acuña-Amador L, Quesada-Gómez C, Rodríguez C. Clostridioides difficile in Latin America: A comprehensive review of literature (1984-2021). Anaerobe 2022;:102547. [PMID: 35337973 DOI: 10.1016/j.anaerobe.2022.102547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lanzas C, Jara M, Tucker R, Curtis S; CDC Modeling Infectious Diseases in Healthcare Program (MinD). A review of epidemiological models of Clostridioides difficile transmission and control (2009-2021). Anaerobe 2022;:102541. [PMID: 35217149 DOI: 10.1016/j.anaerobe.2022.102541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Islam MI, Seo H, Redwan A, Kim S, Lee S, Siddiquee M, Song HY. In Vitro and In Vivo Anti-Clostridioides difficile Effect of a Probiotic Bacillus amyloliquefaciens Strain. J Microbiol Biotechnol 2022;32:46-55. [PMID: 34675143 DOI: 10.4014/jmb.2107.07057] [Reference Citation Analysis]
9 Dilnessa T, Getaneh A, Hailu W, Moges F, Gelaw B. Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis. PLoS ONE 2022;17:e0262597. [DOI: 10.1371/journal.pone.0262597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Motamedi H, Fathollahi M, Abiri R, Kadivarian S, Rostamian M, Alvandi A. A worldwide systematic review and meta-analysis of bacteria related to antibiotic-associated diarrhea in hospitalized patients. PLoS One 2021;16:e0260667. [PMID: 34879104 DOI: 10.1371/journal.pone.0260667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ghia CJ, Waghela S, Rambhad GS. Systematic Literature Review on Burden of Clostridioides difficile Infection in India. Clin Pathol 2021;14:2632010X211013816. [PMID: 34104883 DOI: 10.1177/2632010X211013816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 AlJindan R, AlEraky DM, Borgio JF, AbdulAzeez S, Abdalhamid B, Mahmoud N, Farhat M. Diagnostic deficiencies of C. difficile infection among patients in a tertiary hospital in Saudi Arabia: A laboratory-based case series. Saudi J Biol Sci 2021;28:4472-7. [PMID: 34354432 DOI: 10.1016/j.sjbs.2021.04.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shokoohizadeh L, Alvandi F, Yadegar A, Azimirad M, Hashemi SH, Alikhani MY. Frequency of toxin genes and antibiotic resistance pattern of Clostridioides difficile isolates in diarrheal samples among hospitalized patients in Hamadan, Iran. Gastroenterol Hepatol Bed Bench 2021;14:165-73. [PMID: 33968344] [Reference Citation Analysis]
14 Vieira-pires RS, Morgan PM, Choraria A, Gandhimathi C, Michael A, Ôchoa-pires T, Salimian J, Rajan S, Subramani M. Applications of IgY in Human Medicine. IgY-Technology: Production and Application of Egg Yolk Antibodies 2021. [DOI: 10.1007/978-3-030-72688-1_16] [Reference Citation Analysis]
15 Yu H, Flaster N, Casanello AL, Curcio D. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries. Braz J Infect Dis 2021;25:101040. [PMID: 33290727 DOI: 10.1016/j.bjid.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Doll M, Marra AR, Apisarnthanarak A, Al-Maani AS, Abbas S, Rosenthal VD. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases. Int J Infect Dis 2021;102:188-95. [PMID: 33122100 DOI: 10.1016/j.ijid.2020.10.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Djuikoue IC, Tambo E, Tazemda G, Njajou O, Makoudjou D, Sokeng V, Wandji M, Tomi C, Nanfack A, Dayomo A, Lacmago S, Tassadjo F, Sipowo RT, Kakam C, Djoko AB, Assob CN, Andremont A, Barbut F. Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon. Infect Dis Poverty 2020;9:122. [PMID: 32867842 DOI: 10.1186/s40249-020-00738-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hernández Del Pino RE, Barbero AM, Español LÁ, Morro LS, Pasquinelli V. The adaptive immune response to Clostridioides difficile: A tricky balance between immunoprotection and immunopathogenesis. J Leukoc Biol 2021;109:195-210. [PMID: 32829520 DOI: 10.1002/JLB.4VMR0720-201R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Maestri AC, Raboni SM, Morales HMP, Ferrari LF, Tuon FFB, Losso A, Marconi C, Nogueira KDS. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil. Anaerobe 2020;64:102238. [PMID: 32717474 DOI: 10.1016/j.anaerobe.2020.102238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Khattab RA, Ahmed NA, Ragab YM, Rasmy SA. Bacteria producing antimicrobials against Clostridium difficile isolated from human stool. Anaerobe 2020;63:102206. [PMID: 32339663 DOI: 10.1016/j.anaerobe.2020.102206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Fadda HM. The Route to Palatable Fecal Microbiota Transplantation. AAPS PharmSciTech 2020;21:114. [PMID: 32296975 DOI: 10.1208/s12249-020-1637-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
22 Chen J, Yang H, Sheng Z. Ellagic Acid Activated PPAR Signaling Pathway to Protect Ileums Against Castor Oil-Induced Diarrhea in Mice: Application of Transcriptome Analysis in Drug Screening. Front Pharmacol 2019;10:1681. [PMID: 32082169 DOI: 10.3389/fphar.2019.01681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Karaoui WR, Rustam LBO, Bou Daher H, Rimmani HH, Rasheed SS, Matar GM, Mahfouz R, Araj GF, Zahreddine N, Kanj SS, Berger FK, Gärtner B, El Sabbagh R, Sharara AI. Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: A prospective cohort study. J Infect Public Health 2020;13:485-90. [PMID: 31838001 DOI: 10.1016/j.jiph.2019.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Islam MA, Kabir ND, Moniruzzaman M, Begum K, Ahmed D, Faruque ASG, Garey KW, Alam MJ. Clostridioides difficile ribotypes isolated from domestic environment and from patients in Bangladesh. Anaerobe 2019;56:88-90. [PMID: 30794875 DOI: 10.1016/j.anaerobe.2019.02.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Uzelac-škorić A, Uzelac M, Škorić M, Durlević D, Maris S, Milić M. Occurrences of infections caused by the bacteria clostridium difficile on the territory of Belgrade. Zdravstvena zaštita 2019;48:13-19. [DOI: 10.5937/zz1903013u] [Reference Citation Analysis]